This FDA-Approved Drug Slows Down Alzheimer's. We Finally Know Why.

Lecanemab received FDA approval in January after a phase 3 trial showed it slows cognitive decline in early-stage Alzheimer's patients.

Related Keywords

Rockefeller University ,New York ,United States ,Terin Norris ,Sidney Strickland ,